Follicular Lymphoma Global Clinical Trials Review, H2, 2017

2017-08-23
Price :
Published : Aug-2017
No. of Pages : 750

Follicular Lymphoma Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Follicular Lymphoma Global Clinical Trials Review, H2, 2017” provides an overview of Follicular Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Follicular Lymphoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Curevac AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Curevac AG (Curevac), formerly CureVac GmbH is a clinical stage biopharmaceutical company that develops RNA-based medicines. The company designs, develops and produces messenger RNA molecules for therapeutic and prophylactic vaccines in the fields of oncology and infectious diseases. Its RNA technology platforms include RNAntibody, RNArt, RNActive, and RNAdjuvant. Curevac's RNActive technology is used to develop treatments against cancer and prophylactic vaccines for infectious diseases. The company's RNAdjuvant technology is used to enhance the immune response of other vaccines. Its products are used in the treatment of prostate cancer and non-small cell lung cancer; and infectious diseases such as rabies, rotavirus, influenza, and other undisclosed. The company program the RNA......
$250

Intrexon Corp (XON) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Intrexon Corp (Intrexon), formerly Genomatix Corp is a provider of therapeutic solutions. The company operates through its divisions such as human therapeutics, protein production, industrial products, agricultural biotech, and animal sciences. Its human therapeutics division develops therapeutic product candidates for lysosomal storage diseases, hematological disorders, metabolic diseases, infectious diseases, and autoimmune disorders. Intrexon's UltraVector platform produces and optimizes custom, complex gene systems; mAbLogix platform enables production of B-cell libraries for discovery of antibodies. The company offers RheoSwitch therapeutic system for inducible expression of single and multi-gene systems through an activator ligand. It has partnership with the channel of ne......
$250

Medimetriks Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Medimetriks Pharmaceuticals Inc (MPI) is a drug company that offers skincare products. The company provides personal care products including cleansers, nutritional suppliments, cosmetic creams, and moisturizer. Its products include Centany, Ciclodan, Clindacin ETZ, Genadur, Ketodan, Morgidox, Uramaxin and Rosadan. MPI offers products for the treatment of acne, seborrheic dermatitis, severe dry skin, dystrophic nails and impetigo. The company develops and commercializes skincare products in the Dermatology and Podiatry markets. It also offers products for hair care. The company operates across various states in the US. MPI is headquartered in Fairfield, New Jersey, the US. Medimetriks Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you......
$250

International AIDS Vaccine Initiative – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary International AIDS Vaccine Initiative (IAVI) is a not-for-profit organization that develops preventive HIV vaccine candidates. The organization offers vaccine development through basic research, discovery, preclinical evaluation and manufacturing, and regulatory review, among others. It also conducts policy analysis and performs vaccine trials and epidemiological research. IAVI's product portfolio includes mRNA-NFL, BG505 Envelope, eOD Immunogen, AAV-PG9, AD26, MVA, protein and CDV replicating vector, among others. The organization partners with academic, industry and government organizations and clinical research center. It operates in South Africa, Kenya, India, the US, and the Netherlands. IAVI is headquartered in New York, the US. International AIDS Vaccine Initiative - P......
$250

Laboratorio Teuto Brasileiro SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Laboratorio Teuto Brasileiro SA (Teuto), a subsidiary of Pfizer Inc is a drug company that develops, manufactures, and markets generic and over the counter products. The company's products include aerodini aerosol salbutamol sulphate, afopic folic acid, albentel albendazole, acetato de dexametasona, acetato de hidrocortisona, acetilcisteina, and aciclovir creme, among others. It also provides phytotherapic medicines, food supplements, cosmetics, and hospital line products. Teuto offers its products in the form of liquids, injectables, and eye drops. The company provides outsourced pharmaceutical manufacturing services to national and multinational companies. It markets its products to customers in Central America, South America, and Portugal, among others. Teuto is headquartered......
$250

Laboratorio Reig Jofre SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Laboratorio Reig Jofre SA (Reig Jofre) is a drug company that develops and manufactures medicinal products and nutritional supplements. The company's product categories include specialized technology products, specialty therapeutic areas, and nutritional supplements and consumer healthcare. Its specialized technology products include antibiotics, injectable, and freeze-dried products. Reig Jofre develops products in liquid dosage forms, semi-solid forms, and solid oral dosage forms. The company offers services such as research and development, regulatory services, manufacturing, and licensing of dossiers. It conducts research in the areas of bioequivalence, clinical pharmacokinetics and bioavailability studies, drug interaction, preclinical pharmacokinetics, preclinical toxicoki......
$250

PSR Group BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary PSR Group BV (PSR) is a contract research organization and staffing consultancy that operates through two divisions, namely, PSR Orphan Experts and PSR Pharma Resource. The company's PSR Orphan Experts is a contract research organization that concentrates on orphan drug development. It provides CRO services such as regulatory consultancy, clinical consultancy and clinical study execution services. PSR orphan works in partnership with Agility Clinical to provide orphan drug development access to its clients. The company's Pharma Resource offers recruitment and interim staff management services to pharmaceutical and biotechnology companies in the areas of medical affairs, regulatory affairs, pharmacovigilance, quality assurance and clinical operations. PSR is headquartered in Hoof......
$250

Kinnov Therapeutics SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Kinnov Therapeutics SAS (Kinnov) is a research and development company that discovers and develops therapies against addiction. The company's pipeline product include KT-110, a pharmaceutical composition used as a therapy for addiction diseases. Its antagonist of alpha1-adrenergic receptors are used in the treatment of arterial high blood pressurel; and antagonist of 5HT2 and 5HT1C receptors are used in the treatment of allergy. Kinnova's preclinical research and development addiction include identifying the key receptors of addictions, selecting compounds inhibiting these receptors, developing a therapeutic composition for human and validating the concept on proper animal models. It partners with pharma company to conduct phase III studies for its pipeline product. Kinnov is he......
$250

Phosplatin Therapeutics LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Phosplatin Therapeutics LLC (Phosplatin Therapeutics) is a drug development company that carries out the clinical development of phosphaplatins products. The company develops small-molecule compounds which are used for the treatment of cancer. It has collaborations with various contract research organizations, pharmaceutical companies and universities across various countries to study the mechanism of action of its lead drug candidate PT-112 in advanced solid tumors. The company markets its products through its network of distributors across the US. Phosplatin Therapeutics is headquartered in New York, the US. Phosplatin Therapeutics LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and......
$250

Impax Laboratories Inc (IPXL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Impax Laboratories Inc (Impax) develops, manufactures and markets generic and branded pharmaceuticals. It offers solid dose and alternative dosage form generic drugs in a broad range of therapeutic areas; and proprietary branded pharmaceutical products for the treatment of central nervous system (CNS) disorders and other select specialties. The company also has few product candidates in varying stages of development. Impax developed several controlled-release delivery technologies which can be utilized with a variety of oral dosage forms and drugs. It has manufacturing facilities in Hayward, California; Middlesex, New Jersey; and in Taiwan. The company sells its products directly to wholesalers and large retail drug chains and through unrelated third-party pharmaceutical entitie......
$250